Hikma Ventures – Startup Investor Profile

Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals.

Location: London

Country:

Investment Regions: EU

Investment Stages: pre-seed, seed

Website: https://www.hikmaventures.com/

AI Reasoning: I found a public announcement showing Hikma Ventures participated in Biolinq’s Series C funding which closed on April 22, 2025. The invested startup was Biolinq. The time since that investment is about 6 months and 10 days, which falls within the window for ‘very-active’ (less than 3 months) – however, re-evaluating: April 22, 2025 to November 1, 2025 is more than 6 months. But there is also a Hikma press PDF showing Hikma Ventures invested in Biolinq on 27 November 2017; however the most recent confirmed investment is participation in Biolinq’s Series C on April 22, 2025. That is 192 days before the target date, which is between 3 and 6 months? (192 days ≈ 6.3 months) This places activity between 6 and 3 months, so the correct tag is ‘active’.

Not Active – No known investments in the last 12 months.

Low Activity – Only known investments between the last 12 and 6 months.

Active – Known investments between the last 6 and 3 months.

Very Active – Known investments in the last 3 months.